Simultaneous very late stent thrombosis in multiple coronary arteries

Texas Heart Institute Journal

Volumn 39, Issue 5, 2012, Pages 630-634

  Narasimhan, Seshasayee ^a   Krim, Nassim Rostane ^a   Silverman, Gary ^a   Monrad, Ernest Scott ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Aspirin; Clopidogrel; Coronary restenosis etiology; Coronary thrombosis etiology; Drug delivery systems adverse effects; Immunosuppressive agents; Paclitaxel; Platelet aggregation inhibitors therapeutic use; Sirolimus therapeutic use; Stent thrombosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; CYPHER; ENALAPRIL; IPRATROPIUM BROMIDE; METOPROLOL; RAPAMYCIN; SIMVASTATIN; THIAMAZOLE; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CARDIOGENIC SHOCK; CARDIOVERSION; CASE REPORT; DRUG ELUTING STENT; FEMALE; HEART VENTRICLE FIBRILLATION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; SIROLIMUS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84870170606     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004;109(6):701-5. (Pubitemid 38222887)
2. Karvouni E, Korovesis S, Katritsis DG. Very late thrombosis after implantation of sirolimus eluting stent. Heart 2005;91(6):e45.
3. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005;45(12):2088-92. (Pubitemid 40814135)
4. Kuchuiakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus-and paclitaxel-eluting stents. Circulation 2006;113(8):1108-13.
5. Pinto Slottow TL, Steinberg DH, Roy PK, Buch AN, Okabe T, Xue Z, et al. Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period. Am J Cardiol 2008;102(3):298-303.
6. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007:369(9562):667-78. (Pubitemid 46281313)
7. Ong AT, Hoye A, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Sonnenschein K, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005;45(6):947-53. (Pubitemid 40342824)
8. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Safety and efficacy of sirolimus-and paclitaxel-eluting coronary stents. N Engl J Med 2007:356(10):998-1008. (Pubitemid 46376800)
9. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L; SCARR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356(10):1009-19. (Pubitemid 46376801)
10. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-elutirig stents. N Engl J Med 2007;356(10):1020-9. (Pubitemid 46376802)
11. Jensen LO, Maeng M, Kaltoft A, Thayssen P, Hansen HH, Bottcher M, et al. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol 2007:50(5):463-70. (Pubitemid 47088133)
12. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364(9444):1519-21. (Pubitemid 39410418)
13. Park JS, Kim YJ, Shin DG, Shim BS, Hong GR, Bae JH, et al. Clinical and angiographic outcome of sirolimus-eluting stent for the treatment of very long lesions. Korean Circ J 2006;36(7):490-4.
14. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006;47(10):2108-11.
15. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007:369(9562):667-78. (Pubitemid 46281313)
16. Costa MA, Sabate M, van der Giessen WJ, Kay IP, Cervinka P, Ligthart JM, et al. Late coronary occlusion after intracoronary brachytherapy. Circulation 1999;100(8):789-92. (Pubitemid 29398874)
17. Azarbal B, Currier J W Allergic reactions after the implantation of drug-eluting stents: is it the pill or the polymer? J Am Coll Cardiol 2006;47(1):182-3. (Pubitemid 43005184)
18. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006;47(1):175-81. (Pubitemid 43005183)
19. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48(1):193-202. (Pubitemid 43929240)
20. Virmani R, Farb A, Guagliumi G, Kolodgie FD. Drug-eluting stents: caution and concerns for long-term outcome. Coron Artery Dis 2004;15(6):313-8. (Pubitemid 39299245)
21. Choi BR, Lee CW, Park SW. Late stent thrombosis associated with late stent malapposition after drug-eluting stenting: a case report. Korean Circ J 2006;36(6):472-5. (Pubitemid 44090432)
22. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 2005:45(7):995-8. (Pubitemid 40432428)
23. Sianos G, Hofma S, Ligthart JM, Saia F, Hoye A, Lemos PA, Serruys PW. Stent fracture and restenosis in the drug-eluting stent era. Catheter Cardiovasc Interv 2004;61(1):111-6. (Pubitemid 38036800)
24. Wilczynska J, Rdzanek A, Kochman J, Horszczaruk GJ, Pietrasik A, Opolski G. Sirolimus eluting stent fracture following angioplasty of diffuse in-stent restenosis in the right coronary artery. Int J Cardiol 2007;118(1):126-7. (Pubitemid 46517694)
25. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115(18):2435-41. (Pubitemid 46717966)
26. Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Billinger M, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 2005:46(2):231-6. (Pubitemid 40966848)
27. Inoue K, Mitsudo K, Nobuyoshi M. Abstract 4724: Pathological mechanisms of very late stent thrombosis after drug-eluting stent implantation in human coronary arteries [abstract]. Circulation 2009:120(18 Suppl 2):S993.
28. Nakazawa G, Finn AV, Vorpahl M, Ladich ER, Kolodgie FD, Virmani R. Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus-and paclitaxel-eluting stents. J Am Coll Cardiol 2011;57(4):390-8.
29. Narasimhan S, Srinivas VS, De Rose JJ Jr. Hybrid coronary revascularization: a review. Cardiol Rev 2011;19(3):101-7.